Nitroglycerin Tablet
Product Images NDC 82804-122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 82804-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 06)

FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 07)

FDA Label Image

Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\structure.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 08)

FDA Label Image

82804-122-25 (Ctn0 4mg)

82804-122-25 (Ctn0 4mg)
This is a description of Nitroglycerin 0.4mg sublingual tablets. Each tablet contains 0.4 mg of nitroglycerin. The tablets are white to off white, round, and flat-faced, with "2" debossed on one side and "C" on the other. The tablets should not be crushed, chewed, or swallowed. The medication is manufactured by Glenmark Pharmaceuticals Limited in India and stored at 20°-25°C. The product is relabeled by Proficient Rx LP in Thousand Oaks, CA. Each package contains 25 sublingual tablets, with lot number, NDC, and expiration date provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.